Measurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trials

BACKGROUND: Prediction models for venous thromboembolism recurrence will likely be improved by adding levels of coagulation factors. Risk assessment is ideally performed during anticoagulant treatment, however, the influence of direct oral anticoagulants on coagulation factors is uncertain. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheres, Luuk J. J., Lijfering, Willem M., Middeldorp, Saskia, Cheung, Yuk W., Barco, Stefano, Cannegieter, Suzanne C., Coppens, Michiel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles: Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178718/
https://www.ncbi.nlm.nih.gov/pubmed/30349888
http://dx.doi.org/10.1002/rth2.12142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178718/
https://www.ncbi.nlm.nih.gov/pubmed/30349888
http://dx.doi.org/10.1002/rth2.12142

Ejemplares similares